alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 86, Number 104 (Wednesday, June 2, 2021)]
[Notices]
[Pages 29589-29590]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11569]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Human Genome Research Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the access applications, the disclosure of which

[[Page 29590]]

would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Inherited Disease Research Access 
Committee CIDR Access Committee.
    Date: July 9, 2021.
    Time: 11:30 a.m. to 12:30 p.m.
    Agenda: To review and evaluate access applications.
    Place: National Human Genome Research Institute, National 
Institutes of Health, 6700B Rockledge Drive, Suite 3100, Room 3185, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Barbara J. Thomas, Ph.D., Scientific Review 
Officer, Scientific Review Branch, National Human Genome Research 
Institute, National Institutes of Health, 6700B Rockledge Drive, 
Suite 3100, Room 3185, Mail Stop Code 6908, Bethesda, MD 20892, 301-
402-8837, <a href="/cdn-cgi/l/email-protection#365457445457445718425e595b574576585f5e18515940"><span class="__cf_email__" data-cfemail="f795968595968596d9839f989a9684b7999e9fd9909881">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human 
Genome Research, National Institutes of Health, HHS)

David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-11569 Filed 6-1-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

July 23, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-5687

Alo USA Inc:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request did not contain a sufficient product identification or was 

determined to be non-administrable.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Joseph Barloon

General Counsel
Exhibit 13.2





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Annual Report of Gilat Satellite Networks Ltd. (the “Company”) on Form 20-F for the period ending December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ari Krashin, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:





(1)  The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.




/s/ Ari Krashin*


Ari Krashin


Chief Financial Officer





April 12, 2011





*The originally executed copy of this Certification will be maintained at the Company’s offices and will be made available for inspection upon request.





This certification accompanies this Annual Report on Form 20-F pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act").  Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.
Exhibit 31.1

CERTIFICATION



I, Paul A. Parisotto, certify that:

1.          
I have reviewed this quarterly report on Form 10-Q ofBlacksands Petroleum, Inc.

2.          Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.          Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this report;

4.          
The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



(a)          
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;



(b)          
Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such
evaluation; and



(c)          
Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting.



5.          The issuers other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the issuers auditors and the audit committee of the issuers board of directors (or persons performing the equivalent functions):

(a)          All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the issuers ability to record, process, summarize and report financial information; and

(b)          Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuers internal control over financial reporting.





|Date:    May 6, 2009 |                                                | By:Paul A. Parisotto
|-------------------- | ---------------------------------------------- | --------------------
|                     | Paul A. Parisotto, Principal Executive Officer
|                     |                                                |
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

May 7, 2019

RE: Product Exclusion Request Number USTR-2018-0025-6649

Nissan North America, Inc:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request concerns a product strategically important or related to 

“Made in China 2025” or other Chinese industrial programs.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Joseph Barloon

General Counsel
#### David Allen CHAMBERLAIN, Respondent, v. STATE of Missouri, DIRECTOR OF REVENUE, Appellant.

No. 68964.

Missouri Court of Appeals, Eastern District. Division One.

April 30, 1996.

Jeremiah W. (Jay) Nixon, Atty. Gen., Rodney P. Massman, Special Assistant Atty. Gen., Missouri Department of Revenue, Jefferson City, for appellant.

Michael J. Smith, St. Louis, for respondent.

KAROHL, Judge.

The Director of Revenue (DOR) attempts to appeal an order reinstating David Allen Chamberlain’s driving privileges pursuant to § 302.500 et seq. RSMo 1994.1

Chamberlain’s driving license was suspended as a result of allegedly driving under the influence with a blood alcohol level of .10. He requested an administrative hearing under § 302.505, which sustained the suspension. He petitioned for a trial de novo hearing under § 302.535. The case was assigned to a traffic court commissioner. The traffic court commissioner heard the ease and found Chamberlain’s driving privileges should be reinstated. The commissioner found the arresting officer had probable cause to arrest Chamberlain, but he did not have a blood alcohol concentration of .10 or more.

Before addressing the issues on appeal, we have an affirmative duty to determine whether we have jurisdiction. *Webster v. City of Cool Valley,*838 S.W.2d 520 (Mo.App.E.D.1992).

We find the order is without legal effect. Section 302.500 et seq. provides a comprehensive procedure to review a suspension or revocation of a drivers’ license. Under § 302.535.1, the petition for trial de novo shall be filed in the circuit court, heard and *139decided by a circuit judge or an associate circuit judge, not a traffic court judge or commissioner. *State of Missouri ex rel. Coyle v. O’Toole,*914 S.W.2d 871 (Mo.App. E.D.1996). Also, a traffic court commissioner is not authorized by § 479.500 to hear a drivers’ license suspension or revocation trial de novo. *Id.*

Chamberlain’s petition remains pending in the circuit court. We remand for a hearing.

REINHARD, P.J., and GRIMM, J., concur.

1

. All statutory references are to RSMo 1994.
#### Verlon D. TOLLETT, Appellant, v. The STATE of Texas, Appellee.

No. 0472-87.

Court of Criminal Appeals of Texas, En Banc.

Nov. 9, 1988.

Rehearing Denied Dec. 14, 1988.

Randy T. Leavitt, Terrence W. Kirk, Austin, for appellant.

Ken Anderson, Dist. Atty., Georgetown, Robert Huttash, State’s Atty., Austin, for the State.

*377OPINION ON APPELLANT’S PETITION FOR DISCRETIONARY REVIEW

PER CURIAM.

Appeal is taken from a conviction for the offense of Aggravated Sexual Assault. After finding appellant guilty, the jury assessed punishment at 99 years confinement in the Texas Department of Corrections.

On direct appeal, Appellant argued the trial court erred in instructing the jury on the law concerning good time and parole, inasmuch as the charge is predicated upon an unconstitutional statute. The Court of Appeals rejected appellant’s challenge to Article 37.07, Sec. 4, V.A.C.C.P. *Tollett v. State,*727 S.W.2d 714 (Tex.App.—Austin, 1987).

In his petition for discretionary review, Appellant urges the Court of Appeals erred in holding Article 37.07, Sec. 4, supra, is constitutional. We find appellant is correct.

In *Rose v. State,*752 S.W.2d 529 (Tex.Crim.App.1988), this Court determined that Article 37.07, Sec. 4, is unconstitutional. Under *Rose,*supra, it is still necessary for the Court of Appeals to conduct a harmless error analysis under the guidelines of Tex. R.App.P. 81(b)(2).

The judgment of the Court of Appeals is vacated, and this cause is remanded to that Court for further proceedings consistent with this opinion.
Exhibit 10.4


 


AMENDMENT NO.     TO THE RESTRICTED STOCK AWARD AGREEMENT


BETWEEN DOUGLAS R. LEBDA AND TREE.COM, INC.


 


[Date]


 


This
Amendment No.    to that certain Restricted Stock Award
Agreement, dated as of [DATE] (the “Agreement”) between Douglas R. Lebda (“Employee”)
and Tree.com (the “Company”) is effective as of [DATE], unless otherwise
indicated.  All capitalized terms used
herein without definition shall have the meanings given to them in the
Agreement.


 


WHEREAS, subject to the terms and conditions set forth
herein, Employee and the Company wish to make certain amendments to the
Agreement.


 


NOW, THEREFORE, for good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the parties hereby
agree as follows:


 


1.             Section 2 of the
Agreement is hereby deleted and replaced in its entirety with the following:


 


“2.                                 In order for your Award to
vest, you must be continuously employed by Tree.com or any of its Subsidiaries
or Affiliates during the Restriction Period (as defined below).  Notwithstanding the foregoing or any other
provision to the contrary in the Plan or this Agreement, you shall become 100%
vested in your Award upon the occurrence of a Change in Control.  Nothing in this Agreement or the Plan shall
confer upon you any right to continue in the employ or service of Tree.com or
any of its Subsidiaries or Affiliates or interfere in any way with their rights
to terminate your employment or service at any time.”


 


2.             Except as explicitly set
forth herein, the remaining provisions of the Agreement will remain in full
force and effect.


 


* * * Signature Page to Follow * * *


 

















 


IN
WITNESS WHEREOF, the parties have executed this Amendment No.    as of
the date first set forth above.


 


 


	
   

  	
  TREE.COM,
  INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:
  Claudette Hampton

  
	
   

  	
  Senior
  Vice President — Human Resources

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  EMPLOYEE

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  Douglas
  R. Lebda
**Exhibit 32.1**

**Certification of the Chief Executive Officer**

**Pursuant to 18 U.S.C. Section 1350,**

**As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

In connection with the Quarterly Report of WMG Acquisition Corp. (the “Company”) on Form 10-Q for the period ended December 31, 2007 asfiled with the Securities and Exchange Commission on the date hereof (the “Report”), I, Edgar Bronfman, Jr., Chief Executive Officer of the Company certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that: 

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and 

(2) the information contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company. 

Dated: February 6, 2008 

 

 

55
<PAGE>

EXHIBIT 31.1

CERTIFICATION

I, James Joyce, certify that:

1. I have reviewed this report on Form 10-KSB of Aethlon Medical, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report.

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

         a) designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

         b) evaluated the effectiveness of the registrant's disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and

         c) disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's most
recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

         a) all significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

         b) any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's internal control
over financial reporting.

Date: June 29, 2004

                                             /s/ James A. Joyce
                                             -----------------------------------
                                             James A. Joyce
                                             Chief Executive Officer
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5119 Referred in Senate (RFS)]

<DOC>
118th CONGRESS
  1st Session
                                H. R. 5119

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           December 13, 2023

Received; read twice and referred to the Committee on Banking, Housing, 
                           and Urban Affairs

_______________________________________________________________________

                                 AN ACT

 
To amend title 31, United States Code, to provide small businesses with 
additional time to file beneficial ownership information, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Protect Small Business and Prevent 
Illicit Financial Activity Act''.

SEC. 2. BENEFICIAL OWNERSHIP INFORMATION REPORTING DEADLINES FOR SMALL 
              BUSINESSES.

    Section 5336(b)(1) of title 31, United States Code, is amended--
            (1) in subparagraph (B)--
                    (A) by inserting ``(but which may not adjust the 
                report submission deadline)'' after ``Treasury''; and
                    (B) by striking ``in a timely manner, and'';
            (2) in subparagraph (C)--
                    (A) by inserting ``(but which may not adjust the 
                report submission deadline)'' after ``Treasury''; and
                    (B) by striking ``at the time of'' and inserting 
                ``not later than 90 days after the date of such'';
            (3) in subparagraph (D)--
                    (A) by inserting ``(but which may not adjust the 
                report submission deadline)'' after ``Treasury''; and
                    (B) by striking ``in a timely manner, and not later 
                than 1 year'' and inserting ``not later than 90 days''; 
                and
            (4) by adding at the end the following:
                    ``(H) Unable to obtain.--FinCEN may not by rule, 
                guidance, or otherwise, permit a reporting company from 
                submitting a report relating to the inability of the 
                reporting company to obtain or identify information in 
                the alternative to submitting a report required under 
                this subsection.''.

            Passed the House of Representatives December 12, 2023.

            Attest:

                                             KEVIN F. MCCUMBER,

                                                                 Clerk.
```